Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 1/13/2025J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
  • 1/13/2025Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
  • 1/12/2025WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
  • 1/11/2025Sanofi's Sarclisa (Isatuximab) Approved in China, Pioneering Use of Re...
  • 1/11/2025China Approves Combination Therapy of Padcev and Keytruda
  • 1/11/2025Merck's Gardasil 4 Receives New Indication Approval for Males in China
  • 1/11/2025U.S. FDA Granted Priority Review to Dizal's Sunvozertinib NDA
  • 1/6/2025GSK's Nucala Gains Expanded Approval in China for CRSwNP Treatment
  • 1/6/2025Chinese Researchers Use AI to Accelerates Discovery of Potential Glauc...
  • 1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...
  • 1/3/2025Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China
  • 1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
  • 1/3/2025Biocon Wins NMPA Approval for Tacrolimus Capsules in China
  • 12/30/2024TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...
  • 12/30/2024NMPA Approves Alpha/AZ's Zorifer for NSCLC
  • 12/30/20242025 New Drug Outlook: Increasing Global Launch Share of Chinese Innov...
  • 12/30/2024TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...
  • 12/27/2024China's Innovative Drug Approvals in 2024 and Blockbusters Anticipated...
  • 12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
  • 12/25/2024Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/23/2024Ascelia Pharma Secures Chinese Patent for 2nd-Generation Orviglance
  • 12/19/2024FDA Approves Betta/Xcovery's Ensartinib for NSCLC
  • 12/16/2024Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
  • 12/16/2024Everest Medicines Announces Acceptance of the NDA for VELSIPITY
  • 12/15/2024HUTCHMED Announces Breakthru Designation in China for ORPATHYS and TA...
  • 12/15/2024US-China Renew Science and Technology Pact Amid Rising Tensions
  • 12/12/2024ARS Pharma Files for Approval of Neffy in China, Japan and Australia
  • 12/11/2024Generative AI Powers Insilico Medicine's Rapid Development of New IBD ...
  • 12/10/2024Eisai's Dotinurad Approved in China for Gout
  • Page:9/14 Total number of articles:410: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group